CBIH Completes Cannabinoid-Based Melanoma Patent Application Program Focused on …
✦ New CED Clinical Relevance #61 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. CancerResearchCBDAgingCannabinoid ScienceOncologyEpigenetics Clinical Summary CBIH has completed a patent application…
CBD and Colon Cancer: A Promising Hypothesis Built on Preclinical Ground
By influencing the serotonergic system, CBD colorectal cancer serotonergic pathway may confer both protective and potentially deleterious effects during CRC development. This 2025 review synthesizes preclinical evidence without human clinical trials. The…
Surveyed Cancer Patients Worry About Cannabis Access Barriers
Cancer patients face significant cannabis access barriers that influence their symptom management choices. Cost and legal concerns often outweigh clinical guidance, leading to suboptimal treatment. Addressing cannabis access barriers is crucial for…
Tilray Stock Eyes Breakout Week Amid Trump’s Cannabis Order
Tilray stock breakout week is gaining attention due to Trump's cannabis order, which opens new opportunities in the US cancer market. This policy shift may enhance medical cannabis market access. Patients and clinicians should watch for impacts on…
Medicinal Cannabis to Reduce Chemotherapy Side Effects | Adelaide University
Adelaide University is conducting clinical trials on medicinal cannabis chemotherapy nausea relief. This research targets nausea, vomiting, and appetite loss from chemotherapy. Medicinal cannabis chemotherapy nausea relief offers hope where standard…
Exploring Cannabis Use in Cancer Treatment: Patient Safety & Communication
Cannabis use in cancer treatment raises important patient safety concerns and clinical communication needs. Self-medication with cannabis for cancer requires careful oversight to avoid delays in proven therapies. Oncology teams should address cannabis…
Targeting of ibrutinib resistance–driving pathways by miR-28 in ABC-DLBCL – Nature
This study investigates ibrutinib resistance mechanisms in ABC-DLBCL, focusing on the role of miR-28. Understanding these pathways is crucial for advancing lymphoma treatment. The research highlights potential targets to overcome drug resistance.
Leukemia Study Restores Silenced Gene in Mice: Potential Treatment Implications
Leukemia gene silencing research has restored a silenced gene in mice, shedding light on potential new treatments. This preclinical study focuses on epigenetic mechanisms in leukemia. Understanding these mechanisms may inform future therapeutic…
Bill Would Increase Funding for Pediatric Cancer Research in Iowa – YouTube
Pediatric cancer research funding is critical to advancing cannabis-based therapies for symptom management in young patients. This bill aims to increase support for such research in Iowa. Dedicated funding can help address unique pediatric considerations…
The future of cancer research may lie in tricking the immune system, UT researchers say
Emerging cancer immunotherapy drug interactions are a key focus in UT researchers' latest study. This research highlights the evolving role of immune system modulation in oncology. Understanding these interactions is crucial for clinicians managing…